Antiretroviral Therapy Highly Active
Mostrando 25-36 de 306 artigos, teses e dissertações.
-
25. Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients
AIM: To evaluate changes in liver histology in patients with human immunodeficiency virus/hepatitis C virus coinfection non-responders to a suboptimal Interferon+Ribavirine regimen. MATERIALS AND METHODS: We investigated 49 patients with two sequential liver biopsies: 18 were non-responders to Interferon+Ribavirine treatment (Group hepatitis C virus Rx) a
Braz J Infect Dis. Publicado em: 2014-04
-
26. Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis andMycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review
BACKGROUND: The natural history of HIV infection has changed dramatically after the introduction of highly active antiretroviral therapy. Currently, opportunistic illnesses still represent a major cause of death and hospitalization in this population. In this study, we review the trends in opportunistic illnesses incidence rates and compare the results obse
Braz J Infect Dis. Publicado em: 2014-04
-
27. Drogas antirretrovirais e pancreatite aguda em pacientes com HIV/AIDS: existe alguma associação? Revisão da literatura
Em HIV-soropositivos, a incidência de pancreatite aguda pode chegar até 40% ao ano, o que é consideravelmente maior que na população geral, cuja incidência é de 2%. A partir de 1996, com a introdução da terapia antirretroviral combinada, conhecida pela sigla HAART (highly active antiretroviral therapy), o espectro de fatores nocivos ao pâncreas, co
Einstein (São Paulo). Publicado em: 2014-03
-
28. A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management
INTRODUCTION: In recent years, there has been growing concern about an increasing rate of cardiovascular diseases in human immunodeficiency virus-infected patients, which could be associated with side effects of highly active antiretroviral therapy. It is likely that the metabolic disorders related to anti-human immunodeficiency virus treatment will eventual
Braz J Infect Dis. Publicado em: 2013-12
-
29. Nutritional status and CD4 cell counts in patients with HIV/AIDS receiving antiretroviral therapy
Introduction Even with current highly active antiretroviral therapy, individuals with AIDS continue to exhibit important nutritional deficits and reduced levels of albumin and hemoglobin, which may be directly related to their cluster of differentiation 4 (CD4) cell counts. The aim of this study was to characterize the nutritional status of individuals with
Rev. Soc. Bras. Med. Trop.. Publicado em: 2013-12
-
30. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
BACKGROUND: Recent studies showed a high frequency of low bone mineral density (BMD) in HIV-infected patients and no reports have been issued in Turkey. Our aim was to evaluate BMD and risk factors for osteopenia/osteoporosis in HIV-infected patients that attended an outpatient clinic in Istanbul, Turkey. METHOD: In order to determine the prevalence of BMD,
Braz J Infect Dis. Publicado em: 2013-12
-
31. The effects of a diet formulation with oats, soybeans, and flax on lipid profiles and uricemia in patients with AIDS and dyslipidemia
Introduction Although the initiation of highly active antiretroviral therapy (HAART) is accompanied by an attenuation of viral load, metabolic disorders characterized by hyperglycemia, dyslipidemia, and lipodystrophy are often observed in patients under this treatment. Certain foods, such as oat bran, soy protein, and flaxseed, have been shown to improve a
Rev. Soc. Bras. Med. Trop.. Publicado em: 2013-12
-
32. Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy
OBJECTIVE: To evaluate the influence of hepatitis C virus on immunological and virological responses after highly active antiretroviral therapy initiation in human immunodeficiency virus/hepatitis C virus coinfected patients compared to monoinfected human immunodeficiency virus-infected patients. METHODS: The study enrolled 65 human immunodeficiency virus-1-
Braz J Infect Dis. Publicado em: 2013-10
-
33. Oral lesions frequency in HIV-positive patients at a tertiary hospital, Southern Brazil
AIM: To report the frequency of oral lesions in HIV-positive patients on Highly Active Antiretroviral Therapy (HAART), comparing with a non-HIV infected control group, and to correlate the presence of lesions with demographic and clinical features of HIV-seropositive patients. METHODS: A quantitative case-control study was conducted by a dental professional,
Braz. J. Oral Sci.. Publicado em: 2013-09
-
34. Aging with HIV: a practical review
The worldwide elderly population is expected to grow by an additional 694 million people by 2025. By that time, there will be approximately two billion elderly people in the world, most of whom (80%) will be living in developing countries. Based on recent estimates, this population will number over 40 million in 2030 in Brazil and a consequent increase in go
Braz J Infect Dis. Publicado em: 2013-08
-
35. AIDS-related cerebral toxoplasmosis in São Paulo State, Brazil: marked improvements in the highly active antiretroviral therapy-era but the challenges continue
Braz J Infect Dis. Publicado em: 2013-06
-
36. Uso de terapia antirretroviral de gran actividad (TARGA) y transmisión vertical del VIH. Cuba 1989-2008
OBJECTIVES: to describe the use of Highly Active Antiretroviral Therapy (HAART) in HIV-positive Cuban pregnant women and the relationship between the type of mother antiretroviral treatment used during pregnancy and perinatal transmission. METHODS: a cross-sectional study was carried out in 319 children from seropositive mothers, identifying in they HIV infe
Rev. Bras. Saude Mater. Infant.. Publicado em: 2013-06